»Call Us 972.243.4033

»

April 12, 2019
Print page

***********************************
Brakke Consulting’s
Animal Health News & Notes for April 12, 2019
Copyright © Brakke Consulting

Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:

Brakke Consulting news
Pain Management Products report – last week to pre-order
Market research reports

earnings news
Virbac

other news
Alivira
Aquatreck Animal Health
Because Animals
Boehringer Ingelheim
CZ Vaccines
Embark Veterinary
Embrace Pet Insurance
Evonik Industries
Global Stem cell Technology
Halchemix
Hill’s
iM3
IntelGenx
Mars Petcare
Marinnovac
Oxyfresh
Scout Bio
Zinpro

***********************************
BRAKKE CONSULTING
2019 PAIN MANAGEMENT PRODUCTS REPORT
LAST WEEK FOR EARLY ORDER DISCOUNT!

Pain management is one of the leading topics in veterinary medicine today. Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
– overview of acute and chronic pain in small animals
– discussion of the impact of the human opioid crisis on veterinary use of opioids
– review of new products
– estimates of US sales and prices of leading products
– pain management products in development
– review of nutritional supplements used for chronic pain
– review of therapeutic diets for joint care
– discussion of the use of cannabinoids in veterinary pain management
– 2019 survey of 300 small animal veterinarians regarding use of pain management products

Pain Management Products for Dogs and Cats 2019 can be purchased for $5,250 if ordered by April 19, 2019, and $5,750 thereafter. The report will be completed in May. Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at Lfondon@brakkeconsulting.com.

www.BrakkeConsulting.com

***********************************
COMPANY EARNINGS RELEASES

• Virbac reported financial results for the first quarter of 2019. Revenue reached EUR 217.5 million ($244 million), an increase of 12% when compared to the same period in 2018 (+11% at constant exchange rates). (company press release)

**********************************
COMPANY NEWS RELEASES

• Hill’s Pet Nutrition announced the launch of Prescription Diet Gastrointestinal Biome with ActivBiome+ Technology for fiber-responsive GI issues in dogs and cats. (company announcement)

• Mars Petcare announced the launch of Kinship, a platform with the goal of creating new businesses in partnership with pet-focused start-ups and industry collaborators. The division has access to Mars’ data and analytics capabilities, as well as its $100 million venture fund and start-up accelerator program. (Animal Pharm)

• Zinpro announced the launch of ProPath LQ, a metal amino acid complex, for use in liquid applications across all species. (Animal Pharm)

• Embark Veterinary Inc. announced that it raised $10 million in Series A funding. Embark will use the funds to build on its early consumer success and expand its research in canine health and genetic disease. (PRNewswire)

• Scout Bio announced it has secured $20 million from a series B round to support its pipeline of adeno-associated viral (AAV) vector therapies for chronic conditions. The most advanced therapeutic candidate in Scout Bio’s pipeline is designed to deliver long-term expression of feline erythropoietin (EPO) in cats suffering from anemia associated with chronic kidney disease. (Animal Pharm)

• Embrace Pet Insurance announced it was acquired by NSM Insurance Group, a subsidiary of White Mountains Insurance Group. Embrace insured more than 110,000 dogs and cats in 2017. Financial terms were not disclosed. (Todays Veterinary Business)

• Oxyfresh announced a partnership with iM3 veterinary dental company. The collaboration will have iM3 distributing Oxyfresh’s line of gentle, alcohol-free pet dental products in the veterinary industry. (Pet Business)

• Spain’s CZ Vaccines and Ireland’s Marinnovac announced that they have established an aquaculture vaccine and diagnostics business called Aquatreck Animal Health. The new firm will fast-track fish and shrimp disease prevention strategies through collaborations. The firm’s focus is on autogenous, experimental and licensed vaccines, as well as diagnostic services. (Animal Pharm)

• Because Animals Inc, a pet nutrition startup, is introducing a clean meat pet food made from cell-based meat grown using biotechnology, without raising or slaughtering animals. The company will debut its clean meat line of pet foods in early 2020 with a cat treat made from mice. (Pet Product News)

• IntelGenx Corp. announced the availability of its proprietary VetaFilm oral film technology for companion animal drug delivery. The film can be flavored to appeal to companion animals for spontaneous intake and will adhere on contact in the mouth. (Nasdaq.com)

• EU Boehringer Ingelheim announced the launch of Arti-Cell Forte in Europe for the reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses. Arti-Cell Forte, which utilizes specifically primed, chondrogenic induced stem cells, is the first registered stem cell therapy, according to a press release. Arti-Cell Forte is marketed through a partnership between Boehringer Ingelheim and Global Stem cell Technology (GST). (Business wire)

• FRANCE Alivira has launched Insecinor, a deltamethrin based spot-on for cattle & sheep in France with zero withdrawal time for milk. (company press release)

• CANADA Evonik Industries announced an exclusive distribution agreement with Halchemix for the promotion of a methionine feed additive – Mepron – in the Canadian market. Mepron is used to enhance milk production, while reducing feed costs for the dairy industry. It is approved for use in all ruminant species. (Animal Pharm)

***********************************
ANIMAL HEALTH NEWS

• US – VIRULENT NEWCASTLE DISEASE The USDA’s Animal & Plant Health Inspection Service (APHIS) announced April 5 that it has confirmed the presence of virulent Newcastle disease (VND) in a small flock of pet chickens in northern Arizona. This is the first case of VND confirmed in Arizona as part of the current outbreak, and this case is believed to be connected to the current outbreak of VND in California. (Feedstuffs)

• WORLD – ASF The National Pork Producers Council’s (NPPC) board of directors has announced its decision to cancel World Pork Expo 2019 out of an abundance of caution as African swine fever (ASF) continues to spread in China and other parts of Asia. The World Pork Expo, held each June at the Iowa State Fairgrounds in Des Moines, hosts approximately 20,000 visitors over three days, including individuals and exhibitors from ASF-positive regions. (Feedstuffs)

************************************
BRAKKE CONSULTING
MARKET RESEARCH REPORTS

Brakke Consulting is an industry leader in timely market research on topics of high interest to stakeholders in the animal health, pet and veterinary markets. Reports published in the past two years include:

• Pain Management Products for Dogs and Cats (coming May 2019)
• Field Sales and Veterinary Teams (January 2019)
• US Flea Control and Heartworm Markets (December 2018)
• Manufacturer Sales Force Effectiveness Study (December 2018)
• The Companion Animal Veterinary Telehealth Landscape (October 2018)
• Veterinary Practice Home Delivery (May 2018)
• Veterinary Technical Services Study (March 2018)
• Equine Mega Study IV (January 2018)
• Distributor Effectiveness Study (December 2017)
• Cancer in Dogs and Cats (October 2017)
• New Strategies for Health & Performance in US Livestock & Poultry Production (Jan 2017)

Prices for reports vary. For more information about these or other reports, visit our website at https://www.brakkeconsulting.com/our-services/information/multi-client-studies/ or contact us at info@BrakkeConsulting.com.

www.BrakkeConsulting.com

************************************
BRAKKE CONSULTING VIEWPOINT

Based on the amount of news this week, it appears some managers are taking a short break after closing out the first quarter of 2019. We continue to be amazed at the number of new companies or established companies not known for being in the animal health or pet products business entering the space either directly or via agreements with others more familiar with this marketplace. The companion animal business, with its broad range of products – many of which are not drugs or chemicals – continues to attract investments in both the veterinary and OTC channels. It is a dynamic marketplace which it is exciting to be a part of now and in the future.

There is one story in this newsletter that caught my eye: the announcement by Because Animals, Inc. that they will be entering the “clean meat” pet food market in 2020 by producing via biotechnology a cell-based form of mouse meat to be put in a cat treat. Being a cat owner for many years I’m not sure how one should respond to this innovation, other than that I assume real mice would prefer this approach!

Have a great weekend! We hope those of you in the middle of another late season blizzard will be blessed next week with some warm dry weather.

Ron Brakke

**********************************
This electronic newsletter is the sole property of Brakke Consulting.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com.

Brakke Consulting
806 Green Valley Rd
Suite 200
Greensboro, NC 27408